Transparency Market Research (http://www.transparencymarketresearch.com) includes new market research report "Allergic Rhinitis Market" to its huge collection of research reports.
Albany, NY -- (SBWIRE) -- 12/22/2014 -- Allergic Rhinitis is a chronic inflammatory disease of the nasal cavity which causes respiratory problems and affects all age groups. Common symptoms of the disease include sneezing, sore throat, nasal itching and blocked or running nose. The disease often goes unnoticed due to symptoms of the disease coincide with the symptoms of the common cold among humans. Allergic rhinitis can be of three types,such as, perennial, seasonal or both. The allergic rhinitis market can be classified into four major segments based on its treatment, namely, antihistamines, steroids, others and alternative treatment methods.
Early buyers will receive 10% customization on reports
Major driving factors for the growth of allergic rhinitis market include, high prevalence of the disease, increasing respiratory disorders, increasing usage of tobacco and increasing demand for new and innovative treatments. According to the World Health Organization estimates, more than 400 million people suffered from allergic rhinitis from 1996 to 2006. The disease can also be highly potent due to negligence, as many a times it goes unnoticed and improper treatment methods may be adopted. Various researches are going around the world to bring new drugs which will help in improved treatments of the disease. These factors will drive the growth of this market in future.
Geographically, North America is the largest market with the U.S. having highest prevalence of allergic rhinitis disease, followed by the European market. Asia-Pacificis the fastest growing market with increasing prevalence of the disease and increasing awareness about the disease and its treatments, of the population in the region. Globally, Japan has the second highest prevalence of the disease after the U.S. Some of the important players operating in this market are Alcon, Inc., Array BioPharma, Inc., Dainippon Sumitomo Pharma Co., Ltd., Genentech, Inc., GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co., Inc., Nektar Therapeutics, Novartis AG, Revance Therapeutics, Inc., Shionogi & Co., Ltd., and Stallergenes S.A.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter's five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Read More Reports on Pharmaceutical Market:
About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR's experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Inquiry Before Buying
Latest Upcoming Reports:
90 State Street,
Albany NY - 12207
Browse market research blog: